Development and validation of a clinical and genetic model for predicting risk of severe COVID-19

Gillian S Dite1, Nicholas M Murphy1, Richard Allman1

  • 1Genetic Technologies Ltd, Fitzroy, Victoria, Australia.

Insights

A new clinical and genetic model accurately predicts severe coronavirus disease 2019 (COVID-19) risk. This tool is vital for personalized risk assessment, especially where vaccination is limited or refused.

Area of Science:

  • Genetics
  • Epidemiology
  • Biostatistics

Background:

  • Clinical and genetic risk factors for severe coronavirus disease 2019 (COVID-19) are often analyzed separately.
  • Understanding the combined effect of these factors is crucial for accurate risk prediction.
  • Existing models may not fully capture the complex interplay of clinical and genetic predispositions to severe COVID-19.

Purpose of the Study:

  • To develop and validate a combined clinical and genetic model for predicting severe COVID-19 risk.
  • To assess the predictive performance of the new model compared to existing tools.
  • To provide a tool for individual risk stratification in diverse populations.

Main Methods:

  • Utilized multivariable logistic regression on a large dataset of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive participants from the UK Biobank.
  • A 70% training dataset was used for model development, with the remaining 30% reserved for validation.
  • Model performance was evaluated using discrimination (Area Under the Receiver Operating Characteristic Curve) and calibration metrics.

Main Results:

  • The developed clinical and genetic model demonstrated significant association with severe COVID-19 in the validation dataset (OR=1.77 per quintile).
  • The model achieved acceptable discrimination with an Area Under the ROC Curve of 0.732.
  • Calibration analysis confirmed no significant over- or under-estimation or dispersion of predicted risk.

Conclusions:

  • Accurate prediction of individual risk for severe COVID-19 is achievable through integrated clinical and genetic modeling.
  • This predictive tool holds significant importance in areas with limited vaccine availability or vaccine hesitancy.
  • The model's utility is underscored by ongoing concerns regarding vaccine effectiveness against new variants and transmission dynamics.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
469